These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 28928183)

  • 1. Assessing the extent of drug interactions among patients with multimorbidity in primary and secondary care in the West Midlands (UK): a study protocol for the Mixed Methods Multimorbidity Study (MiMMS).
    Backman R; Weber P; Turner AM; Lee M; Litchfield I
    BMJ Open; 2017 Sep; 7(9):e016713. PubMed ID: 28928183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the polypharmacy challenge in older people with multimorbidity (APOLLO-MM): study protocol for an in-depth ethnographic case study in primary care.
    Swinglehurst D; Fudge N
    BMJ Open; 2019 Aug; 9(8):e031601. PubMed ID: 31444195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a process evaluation of a cluster randomised controlled trial to improve management of multimorbidity in general practice: the 3D study.
    Mann C; Shaw A; Guthrie B; Wye L; Man MS; Hollinghurst S; Brookes S; Bower P; Mercer S; Salisbury C
    BMJ Open; 2016 May; 6(5):e011260. PubMed ID: 27147391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
    Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
    Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
    Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
    BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia.
    Mc Namara KP; Breken BD; Alzubaidi HT; Bell JS; Dunbar JA; Walker C; Hernan A
    Age Ageing; 2017 Mar; 46(2):291-299. PubMed ID: 27836856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions on artificial intelligence-based decision-making for coexisting multiple long-term health conditions: protocol for a qualitative study with patients and healthcare professionals.
    Gunathilaka NJ; Gooden TE; Cooper J; Flanagan S; Marshall T; Haroon S; D'Elia A; Crowe F; Jackson T; Nirantharakumar K; Greenfield S
    BMJ Open; 2024 Feb; 14(2):e077156. PubMed ID: 38307535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structured medication reviews for adults with multimorbidity and polypharmacy in primary care: a systematic review protocol.
    Lammila-Escalera E; Greenfield G; Aldakhil R; Zaman H; Neves AL; Majeed A; Wj Hayhoe B
    BMJ Open; 2024 May; 14(5):e082825. PubMed ID: 38806416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the management of multimorbidity in general practice: protocol of a cluster randomised controlled trial (The 3D Study).
    Man MS; Chaplin K; Mann C; Bower P; Brookes S; Fitzpatrick B; Guthrie B; Shaw A; Hollinghurst S; Mercer S; Rafi I; Thorn J; Salisbury C
    BMJ Open; 2016 Apr; 6(4):e011261. PubMed ID: 27113241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of patients' and healthcare professionals' perspectives on kidney failure risk and the use of the kidney failure risk equation in MULTIPle lOng-term condItions aNd frailTy (MULTIPOINT) study: a qualitative interview and focus group study protocol.
    Walker H; Sullivan MK; Jani BD; Mark PB; Gallacher KI
    BMJ Open; 2024 Oct; 14(10):e085843. PubMed ID: 39424379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.
    Del Cura-González I; López-Rodríguez JA; Leiva-Fernández F; Gimeno-Feliu LA; Pico-Soler V; Bujalance-Zafra MJ; Domínguez-Santaella M; Polentinos-Castro E; Poblador-Plou B; Ara-Bardají P; Aza-Pascual-Salcedo M; Rogero-Blanco M; Castillo-Jiménez M; Lozano-Hernández C; Gimeno-Miguel A; González-Rubio F; Medina-García R; González-Hevilla A; Gil-Conesa M; Martín-Fernández J; Valderas JM; Marengoni A; Muth C; Prados-Torres JD; Prados-Torres A;
    Trials; 2022 Jun; 23(1):479. PubMed ID: 35681224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.
    Linnet K; Gudmundsson LS; Birgisdottir FG; Sigurdsson EL; Johannsson M; Tomasdottir MO; Sigurdsson JA
    BMC Fam Pract; 2016 Jun; 17():69. PubMed ID: 27267943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial.
    Muth C; Uhlmann L; Haefeli WE; Rochon J; van den Akker M; Perera R; Güthlin C; Beyer M; Oswald F; Valderas JM; Knottnerus JA; Gerlach FM; Harder S
    BMJ Open; 2018 Feb; 8(2):e017740. PubMed ID: 29478012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel.
    Sinnott C; Mercer SW; Payne RA; Duerden M; Bradley CP; Byrne M
    Implement Sci; 2015 Sep; 10():132. PubMed ID: 26404642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial.
    Sheppard JP; Burt J; Lown M; Temple E; Benson J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Little P; Mant J; Mollison J; Nickless A; Ogburn E; Payne R; Williams M; Yu LM; McManus RJ
    BMJ Open; 2018 Oct; 8(9):e022930. PubMed ID: 30287610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial.
    Croke A; Moriarty F; Boland F; McCullagh L; Cardwell K; Smith SM; Clyne B
    BMJ Open; 2021 Mar; 11(3):e041541. PubMed ID: 33753432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions.
    Green AR; Lee P; Reeve E; Wolff JL; Chen CCG; Kruzan R; Boyd CM
    J Am Board Fam Med; 2019; 32(3):383-391. PubMed ID: 31068402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.